HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 279, Issue 5, 3817-3827, January 30, 2004

This Article Full Text Full Text (PDF) All Versions of this Article: 279/5/3817    most recent M310991200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Landree, L. E. Articles by Ronnett, G. V. Search for Related Content PubMed PubMed Citation Articles by Landree, L. E. Articles by Ronnett, G. V. Social Bookmarking                      What's this?

C75, a Fatty Acid Synthase Inhibitor, Modulates AMP-activated Protein Kinase to Alter Neuronal Energy Metabolism^*

Leslie E. Landree, Andrea L. Hanlon, David W. Strong, Gavin Rumbaugh, Ian M. Miller, Jagan N. Thupari¶, Erin C. Connolly, Richard L. Huganir, Christine Richardson||, Lee A. Witters**, Francis P. Kuhajda¶, and Gabriele V. Ronnett¶¶||||

From the Departments of Neuroscience, ^¶¶Neurology, ^¶Pathology, Oncology, and Biological Chemistry, The Johns Hopkins University School of Medicine and The Howard Hughes Medical Institute, Baltimore, Maryland 21205 and the ^||Endocrine-Metabolism Division, the Departments of Medicine and Biochemistry, Dartmouth Medical School and the ^**Department of Biological Sciences, Dartmouth College, Hanover, New Hampshire 03755

C75, a synthetic inhibitor of fatty acid synthase (FAS), is hypothesized to alter the metabolism of neurons in the hypothalamus that regulate feeding behavior to contribute to the decreased food intake and profound weight loss seen with C75 treatment. In the present study, we characterize the suitability of primary cultures of cortical neurons for studies designed to investigate the consequences of C75 treatment and the alteration of fatty acid metabolism in neurons. We demonstrate that in primary cortical neurons, C75 inhibits FAS activity and stimulates carnitine palmitoyltransferase-1 (CPT-1), consistent with its effects in peripheral tissues. C75 alters neuronal ATP levels and AMP-activated protein kinase (AMPK) activity. Neuronal ATP levels are affected in a biphasic manner with C75 treatment, decreasing initially, followed by a prolonged increase above control levels. Cerulenin, a FAS inhibitor, causes a similar biphasic change in ATP levels, although levels do not exceed control. C75 and cerulenin modulate AMPK phosphorylation and activity. TOFA, an inhibitor of acetyl-CoA carboxylase, increases ATP levels, but does not affect AMPK activity. Several downstream pathways are affected by C75 treatment, including glucose metabolism and acetyl-CoA carboxylase (ACC) phosphorylation. These data demonstrate that C75 modulates the levels of energy intermediates, thus, affecting the energy sensor AMPK. Similar effects in hypothalamic neurons could form the basis for the effects of C75 on feeding behavior.

Received for publication, October 6, 2003 , and in revised form, November 6, 2003.

^* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

^|||| To whom correspondence should be addressed: Dept. of Neuroscience, 1006B Preclinical Teaching Building, Johns Hopkins University School of Medicine, 725 North Wolfe St., Baltimore, MD 21205. Tel.: 410-614-6482; Fax: 410-614-8033; E-mail: gronnett{at}jhmi.edu.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. R. Bloom, F. P. Kuhajda, I. Laher, X. Pi-Sunyer, G. V. Ronnett, T. M.M. Tan, and D. S. Weigle The Obesity Epidemic: Pharmacological Challenges Mol. Interv., April 1, 2008; 8(2): 82 - 98. [Abstract] [Full Text] [PDF]

				S. Qin and G. W. De Vries {alpha}2 but Not {alpha}1 AMP-activated Protein Kinase Mediates Oxidative Stress-induced Inhibition of Retinal Pigment Epithelium Cell Phagocytosis of Photoreceptor Outer Segments J. Biol. Chem., March 14, 2008; 283(11): 6744 - 6751. [Abstract] [Full Text] [PDF]

				A. L. Vavere, S. J. Kridel, F. B. Wheeler, and J. S. Lewis 1-11C-Acetate as a PET Radiopharmaceutical for Imaging Fatty Acid Synthase Expression in Prostate Cancer J. Nucl. Med., February 1, 2008; 49(2): 327 - 334. [Abstract] [Full Text] [PDF]

				S. Aja, L. E. Landree, A. M. Kleman, S. M. Medghalchi, A. Vadlamudi, J. M. McFadden, A. Aplasca, J. Hyun, E. Plummer, K. Daniels, et al. Pharmacological stimulation of brain carnitine palmitoyl-transferase-1 decreases food intake and body weight Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2008; 294(2): R352 - R361. [Abstract] [Full Text] [PDF]

				H. Orita, J. Coulter, C. Lemmon, E. Tully, A. Vadlamudi, S. M. Medghalchi, F. P. Kuhajda, and E. Gabrielson Selective Inhibition of Fatty Acid Synthase for Lung Cancer Treatment Clin. Cancer Res., December 1, 2007; 13(23): 7139 - 7145. [Abstract] [Full Text] [PDF]

				W. Zhou, W. F. Han, L. E. Landree, J. N. Thupari, M. L. Pinn, T. Bililign, E. K. Kim, A. Vadlamudi, S. M. Medghalchi, R. El Meskini, et al. Fatty Acid Synthase Inhibition Activates AMP-Activated Protein Kinase in SKOV3 Human Ovarian Cancer Cells Cancer Res., April 1, 2007; 67(7): 2964 - 2971. [Abstract] [Full Text] [PDF]

				C. D.L. Folmes and G. D. Lopaschuk Role of malonyl-CoA in heart disease and the hypothalamic control of obesity Cardiovasc Res, January 15, 2007; 73(2): 278 - 287. [Abstract] [Full Text] [PDF]

				G. R. Steinberg, M. J. Watt, B. C. Fam, J. Proietto, S. Andrikopoulos, A. M. Allen, M. A. Febbraio, and B. E. Kemp Ciliary Neurotrophic Factor Suppresses Hypothalamic AMP-Kinase Signaling in Leptin-Resistant Obese Mice Endocrinology, August 1, 2006; 147(8): 3906 - 3914. [Abstract] [Full Text] [PDF]

				S. Ramamurthy and G. V. Ronnett Developing a head for energy sensing: AMP-activated protein kinase as a multifunctional metabolic sensor in the brain J. Physiol., July 1, 2006; 574(1): 85 - 93. [Abstract] [Full Text] [PDF]

				S. Aja, S. Bi, S. B. Knipp, J. M. McFadden, G. V. Ronnett, F. P. Kuhajda, and T. H. Moran Intracerebroventricular C75 decreases meal frequency and reduces AgRP gene expression in rats Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2006; 291(1): R148 - R154. [Abstract] [Full Text] [PDF]

				R. Wang, C. Cruciani-Guglielmacci, S. Migrenne, C. Magnan, V. E. Cotero, and V. H. Routh Effects of Oleic Acid on Distinct Populations of Neurons in the Hypothalamic Arcuate Nucleus Are Dependent on Extracellular Glucose Levels J Neurophysiol, March 1, 2006; 95(3): 1491 - 1498. [Abstract] [Full Text] [PDF]

				Z. Hu, Y. Dai, M. Prentki, S. Chohnan, and M. D. Lane A Role for Hypothalamic Malonyl-CoA in the Control of Food Intake J. Biol. Chem., December 2, 2005; 280(48): 39681 - 39683. [Abstract] [Full Text] [PDF]

				L. D. McCullough, Z. Zeng, H. Li, L. E. Landree, J. McFadden, and G. V. Ronnett Pharmacological Inhibition of AMP-activated Protein Kinase Provides Neuroprotection in Stroke J. Biol. Chem., May 27, 2005; 280(21): 20493 - 20502. [Abstract] [Full Text] [PDF]

				Z. Hu, S. H. Cha, G. van Haasteren, J. Wang, and M. D. Lane From the Cover: Effect of centrally administered C75, a fatty acid synthase inhibitor, on ghrelin secretion and its downstream effects PNAS, March 15, 2005; 102(11): 3972 - 3977. [Abstract] [Full Text] [PDF]

				V. Locatelli and A. Torsello Pyruvate and Satiety: Can We Fool the Brain? Endocrinology, January 1, 2005; 146(1): 1 - 2. [Full Text] [PDF]

				E.-K. Kim, I. Miller, S. Aja, L. E. Landree, M. Pinn, J. McFadden, F. P. Kuhajda, T. H. Moran, and G. V. Ronnett C75, a Fatty Acid Synthase Inhibitor, Reduces Food Intake via Hypothalamic AMP-activated Protein Kinase J. Biol. Chem., May 7, 2004; 279(19): 19970 - 19976. [Abstract] [Full Text] [PDF]